For example, miRNA-17 ~ 92 cluster is overexpressed in MM patients and has oncogenic properties [14], whereas the silencing of tumor suppressor miR-194-2-192 miRNA cluster impairs the p53/MDM2 pathway and favors MM development. The gene discussed is MDM2; the disease is Miyoshi myopathy.